US Dept of Justice to Arraign PharmacyChecker Exec on Counterfeit and Mislabeled Drugs Charges

Published on: 

August 18, 2015.

In a U.S. Department of Justice (DOJ) indictment handed down by a grand jury in November 2014 and unsealed on August 11, 2015, the Director of Pharmacy Policy and International Verifications for New York-based, Ram Kamath, PharmD, and Winnipeg-based are among fourteen individuals and companies charged with crimes related to the sale of $78 million worth of mislabeled and counterfeit prescription drugs, including smuggling, improper storage, falsifying customs declarations, money laundering and conspiracy.

Kamath will be arraigned in a U.S. federal court on Tuesday, August 25. The other defendants, located outside the U.S., have not yet been extradited to face the charges.


Source: PR Newswire